Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300625 · ClinicalTrials.gov registry record
Validation of the San Francisco Syncope Rule
A clinical trial of Syncope and Near Syncope, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 1
- Study location
NCT00300625 is a study of Syncope and Near Syncope that has completed, run by Albert Einstein College of Medicine. The trial reports 1 study location across 1 state.
The verdict
NCT00300625, a study of Syncope and Near Syncope, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Department who had an episode of syncope (passed out) or near syncope (almost passed out). A rule that considers patients with an abnormal ECG, a complaint of shortness of breath, hematocrit less than 30%, systolic blood pressure less than 90 mm Hg, or a history of congestive heart failure was shown predict with a good degree of accuracy which patients would have an adverse event and require admission.
Conditions Studied
Interventions
- PROCEDURE Application of the San Francisco Syncope Rule
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00300625
The ClinicalTrials.gov registry entry for NCT00300625 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Syncope appearing as the primary indexed condition, and to 1 intervention - of which Application of the San Francisco Syncope Rule is the first listed.
NCT00300625 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00300625 about?
NCT00300625 is a clinical study titled "Validation of the San Francisco Syncope Rule". This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Department who had an episode of syncope (passed out) or near syncope (almost passed out). A rule that considers pat...
What is the current status of trial NCT00300625?
This trial is currently completed. The study started on 2005-01.
What conditions does trial NCT00300625 study?
This clinical trial studies the following conditions: Syncope, Near Syncope.
What interventions are being tested in trial NCT00300625?
The interventions under investigation include: Application of the San Francisco Syncope Rule (PROCEDURE).
Who is sponsoring clinical trial NCT00300625?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00300625 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syncope
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
Genetic Markers of Cardiovascular Disease in Epilepsy
RECRUITING
-
BAsel Syncope EvaLuation (BASEL IX) Study
ACTIVE NOT RECRUITING
-
Pediatric Adhesion and New Dermal Approach Study
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.